MILANO, ANNALISA

MILANO, ANNALISA  

DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE  

Mostra prodotti
Risultati 1 - 20 di 26 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life” 2015 Fabbri, M. A.; Santini, D.; Cortesi, E.; Gamucci, T.; Marchetti, Paolo; Longo, F.; Angelini, F.; Sperduti, I.; Milano, Annalisa; Pellegrino, A.; Nelli, F.; Primi, F.; Raffaele, R.; Mancini, M. L.; Quadrini, S.; Giuli, A.; Ruggeri, E. M.
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety 2015 Fabbri, M. A.; Cortesi, E.; Marchetti, Paolo; Santini, D.; Gamucci, T.; Angelini, F.; Longo, F.; Milano, Annalisa; Mancini, M. L.; Giuli, A.; Quadrini, S.; Sperduti, I.; Pellegrino, A.; Ratta, R.; Primi, F.; Chilelli, M. G.; Ruggeri, E. M.
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy 2016 Maria Agnese Fabbri, ; Marchetti, Paolo; Cortesi, Enrico; Santini, Daniele; Teresa, Gamucci; Francesco, Angelini; Isabella, Sperduti; Flavia, Longo; Arianna, Pellegrino; Milano, Annalisa; Silvia, Quadrini; Mancini, Ml; Francesca, Primi; Fabrizio, Nelli; Raffaele, Ratta; Enzo, Ruggeri
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial 2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study 2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? 2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Cancer stem cells in Multiple Myeloma 2011 Ciavarella, S; Milano, Annalisa; Savonarola, A; Brunetti, O; Dammacco, F; Silvestris, F.
Circulating tumor cells count predicts survival in colorectal cancer patients. 2014 Romiti, Adriana; Raffa, Salvatore; R., Di Rocco; Roberto, Michela; Milano, Annalisa; A., Zullo; Leone, Laura; Ranieri, Danilo; F., Mazzetta; E., Medda; I., Sarcina; Barucca, Viola; C., D'Antonio; V., Durante; Ferri, Mario; Torrisi, Maria Rosaria; Marchetti, Paolo
clinicAl outcomes in pAtients with colorectAl cAncer And liver metAstAses: “the times they Are A-chAnging” 2013 Romiti, A; Milano, Annalisa; Balducci, G; Ferri, M; Roberto, Michela; D’Antonio, C; Durante, V; Mazzuca, F; Marchetti, P; Ziparo, V.
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial 2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer 2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 2022 Schipilliti, Fm; Onorato, M; Arrivi, G; Panebianco, M; Lerinò, D; Milano, A; Roberto, M; Capalbo, C; Mazzuca, F
Epithelial and mesenchymal molecular markers in circulating tumor cells (CTCs) from non small cells lung cancer (NSCLC) patients. 2014 Milano, Annalisa; Mazzetta, Francesca; Raffa, Salvatore; Valente, Sabatino; Lauro, Salvatore; Paris, Ida; Torrisi, Maria Rosaria; Marchetti, Paolo
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art 2016 Falcone, Rosa; Roberto, Michela; D'Antonio, Chiara; Romiti, Adriana; Milano, Annalisa; Onesti, CONCETTA ELISA; Marchetti, Paolo; Fais, Stefano
Lapatinib nel tumore mammario metastatico HER2-positivo. suggerimenti dall’ Esmo 2014 2015 Arpino, Grazia; Milano, Annalisa
Le metastasi ossee: aspetti patogenetici e clinici. 2010 Milano, Annalisa; Stucci, S; Strippoli, S; Silvestris, F.
Lenalidomide in multiple myeloma: current experimental and clinical data. 2012 Cives, M; Milano, Annalisa; Dammacco, F; Silvestris, F.
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer 2015 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo
Molecular detection of EMT markers in circulating tumor cells from metastatic non-small cell lung cancer patients. Potential role in clinical practice 2018 Milano, Annalisa; Mazzetta, Francesca; Valente, Sabatino; Ranieri, Danilo; Leone, Laura; Botticelli, Andrea; Onesti, Concetta Elisa; Lauro, Salvatore; Raffa, Salvatore; Torrisi, Maria Rosaria; Marchetti, Paolo
mthfr c677t gene polymorphisms And susceptibility to cArdiovAsculAr Adverse events in metAstAtic colorectAl cAncer treAted with chemotherApy plus bevAcizumAb 2013 D’Antonio, C; Romiti, A; Lombardini, A; Durante, V; Milano, Annalisa; Mazzuca, Federica; Sarcina, I; Falcone, Rosa; Onesti, Ce; Iacono, D; Righini, R; Palombi, L; Marchetti, Paolo